Search results
We found 12 document(s) tagged with Significant cancer
Improved prediction of biopsy outcome using prostate cancer gene 3 (PCA3) in men undergoing an initial biopsy
This poster was presented by Dr. de la Taille at the 24th annual congress of the EAU, 17-21 March 2009 in Stockholm, Sweden.
Submitted by Ismar Healthcare on 2009/04/02- Keywords:
- First biopsy
- Gleason score
- HGPIN
- PCA3 Score
- Prostate cancer
- PSA
- ROC curve
- Sensitivity
- Significant cancer
- Specificity
PCA3 Patient brochure (Spanish)
Submitted by on 2010/06/14- Keywords:
- Active surveillance
- Biopsy
- Diagnosis
- Gene-based marker
- PCA3
- PCA3 Score
- Prostate cancer
- Prostate cancer specific
- Prostate volume
- PSA
- Significant cancer
PCA3 Patient brochure (Italian)
Submitted by Ismar Healthcare on 2009/10/26- Keywords:
- Active surveillance
- Biopsy
- Diagnosis
- Gene-based marker
- PCA3
- PCA3 Score
- Prostate cancer
- Prostate cancer specific
- Prostate volume
- PSA
- Significant cancer
- Test
Prostate Cancer Antigen 3 (PCA3) is an independent and significant predictor for pathologically insignificant Prostate Cancer (PCa) in men undergoing radical prostatectomy
This poster was presented by Dr. Ward at the 24th annual congress of the European Association of Urology (EAU), 17-21 March 2009 in Stockholm, Sweden.
Submitted by Ismar Healthcare on 2009/04/02- Keywords:
- Active surveillance
- Gleason score
- PCA3 Score
- Multivariate analysis
- Prostate cancer
- PSA
- Significant cancer
- Prostatectomy
The value of the PCA3 Assay in guiding prostate biopsy decision in men with a prior negative biopsy
This abstract was presented as a poster at the 23rd annual meeting of the European Association of Urology (EAU), 26-29 March, 2008, Milan, Italy.
Submitted by Ismar Healthcare on 2009/09/17- Keywords:
- Gleason score
- PCA3
- PCA3 Score
- Prostate cancer
- Prostate volume
- PSA
- Repeat biopsy
- Sensitivity
- Specificity
- Test
- Significant cancer
- Clinical stage
PCA3 Patient brochure (English)
Submitted by Ismar Healthcare on 2009/01/24- Keywords:
- Active surveillance
- Biopsy
- Diagnosis
- DRE
- PCA3
- PCA3 Score
- Prostate cancer
- Prostate cancer specific
- Prostate volume
- PSA
- Significant cancer
- Test
- Gene-based marker
PCA3 Patient brochure (German)
Submitted by Ismar Healthcare on 2008/10/16- Keywords:
- Active surveillance
- Biopsy
- Diagnosis
- DRE
- PCA3
- PCA3 Score
- Prostate cancer
- Prostate cancer specific
- Prostate volume
- Gene-based marker
- PSA
- Significant cancer
- Test
PCA3 Patient brochure (Dutch)
Submitted by Ismar Healthcare on 2009/01/26- Keywords:
- Active surveillance
- Biopsy
- Diagnosis
- Gene-based marker
- PCA3
- PCA3 Score
- Prostate cancer
- Prostate cancer specific
- Prostate volume
- PSA
- Significant cancer
- Test
PCA3 Patient brochure (French)
Submitted by Ismar Healthcare on 2010/02/11- Keywords:
- Active surveillance
- Biopsy
- Diagnosis
- DRE
- Gene-based marker
- PCA3
- PCA3 Score
- Prostate cancer
- Prostate cancer specific
- Prostate volume
- PSA
- Significant cancer
- Test
Urinary markers for prostate cancer (Presentation in French)
This presentation was given by Dr. de la Taille at the 102nd annual meeting of the French Association of Urology, 19-22 November 2008, Paris, France
Submitted by Ismar Healthcare on 2009/04/02- Keywords:
- Diagnosis
- First biopsy
- Gleason score
- Multivariate analysis
- PCA3
- Prostate cancer
- Prostate cancer specific
- PSA
- Repeat biopsy
- Sensitivity
- Significant cancer
- Specificity
- Test
The PCA3 test in the diagnosis of prostate cancer
This presentation was given by Dr. M. Roobol at the 24th annual congress of the EAU, 17-21 March 2009 in Stockholm, Sweden
Submitted by Ismar Healthcare on 2009/04/02- Keywords:
- Biopsy
- Diagnosis
- Gleason score
- Multivariate analysis
- ROC curve
- PCA3
- PCA3 Score
- Prostate cancer
- Prostate cancer specific
- Prostate volume
- PSA
- Sensitivity
- Significant cancer
- Specificity
- Tumour volume
PCA3 shows significant association to prostate cancer volume (PCaV) but no correlation to total prostate volume or serum PSA and separates pathologically insignificant from significant prostate cancer (PCa) in men undergoing radical prostatectomy
This poster was presented by Dr. Chun at the 24th annual congress of the European Association of Urology (EAU), 17-21 March 2009 in Stockholm, Sweden
Submitted by Ismar Healthcare on 2009/09/17- Keywords:
- Gleason score
- PCA3 Score
- Prostate cancer
- Prostate cancer specific
- Prostate volume
- PSA
- Significant cancer
- Tumour volume
- Prostatectomy